Breaking News on Supplements & Nutrition - North AmericaEU edition

Trends > Omega-3

Exclusive interview

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

By Shane Starling , 13-Dec-2012

Loading...

BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.

Walter Dissinger, the president of BASF’s nutrition and health division, explains why BASF was so interested in Equateq and the omega-3 space – from food to pharma.

“Our division has a clear strategy. One of the major ingredients we want to grow in is omega-3, especially when we talk about highly concentrated omega-3 and trying to create new white spaces next to pharma which would be human nutrition,” Dissinger said.

 “So the technology we have acquired here is the pre-requisite to get into these markets..."

“We see omega-3 as one of the most important ingredients with high growth rates going forward especially with highly concentrated omega-3 and that’s where the technology we have acquired here kicks in.”

Dissinger said the facility was now the, “benchmark in separation technologies within BASF.”

He also spoke of the potential synergies between BASF Pharma (Callanish) and Pronova, if its €644m bid for the Norwegian firm is approved – and the back story of patented omega-3 drugs being opened up to generic opposition.

€22m has been committed to the BASF Pharma (Callanish) site – formerly known as Equateq before BASF’s May 2012 take over – that can now churn out 250 tonnes of omega-3 oils at up to 99% purity. Previous output was just 20 tonnes.

Related products

Psychobiotics can feed gut-brain health axis: 'It’s really an exciting frontier,' says professor

Psychobiotics can feed gut-brain health axis: 'It’s really an exciting frontier,' says professor

Professor John Cryan

Chair and head of the Department of Anatomy and Neuroscience,...

Algatech: Functional food on astaxanthin horizon

Algatech: Functional food on astaxanthin horizon

Israeli firm Algatechnologies will work towards gaining approval for its astaxanthin as a novel...

Fed up: Probiotic research veteran issues global call to action

Fed up: Probiotic research veteran issues global call to action

Veteran probiotic researcher professor Gregor Reid is not a happy man. It’s time the...

Industry concerned about data abuse as EFSA fans transparency wings

Industry concerned about data abuse as EFSA fans transparency wings

Euros Jones

Director of regulatory affairs, European Crop Protection Association (ECPA)

Unilever: Healthier food choices must be ‘doable’

Unilever: Healthier food choices must be ‘doable’

Hans Zevenbergen

Cross-category nutrition and health director, Unilever

‘Mini gut’ technology aims to make probiotic research more efficient and cheaper, says TNO

‘Mini gut’ technology aims to make probiotic research more efficient and cheaper, says TNO

A new technology that utilises intestinal stem cells to grown mini gut structures in...

New technologies and academic collaborations will drive evidence and market growth for probiotics

New technologies and academic collaborations will drive evidence and market growth for probiotics

Greater collaboration from both within the industry, and between industry and academics, will help...

The data jungle: Matching gene content to probiotic traits could offer industry fresh hope

The data jungle: Matching gene content to probiotic traits could offer industry fresh hope

The probiotic industry is fighting several big fights at the minute, not least in...

Cargill rides publicity wave with Trehalose functional ingredient

Cargill rides publicity wave with Trehalose functional ingredient

Cargill has weathered a potential media storm concerning its functional ingredient Trehalose.  The ingredient,...

Particulars of GRAS process leave it open to criticism, expert says

Particulars of GRAS process leave it open to criticism, expert says

The GRAS process as it stands in the United States is vulnerable to criticism...

Video: In light of FDA's reticence, professional help critical in NDI submissions

Video: In light of FDA's reticence, professional help critical in NDI submissions

The submissions of New Dietary Ingredient notifications seems as fraught as ever, and part...

Keeping it clean: 3 botanical chiefs pull adulteration weeds

Keeping it clean: 3 botanical chiefs pull adulteration weeds

Antoine Bily, Naturex global R&D director

Christian Artaria, Indena marketing director, Holger Riemensperger, Frutarom general manager,...

Diet and cancer: Polyphenol trial data suggests significant clinical benefit for prostate cancer

Diet and cancer: Polyphenol trial data suggests significant clinical benefit for prostate cancer

Professor Robert Thomas

Consultant oncologist, Addenbrooke's and Bedford, Cambridge University Hospital

Are doctors seeing the preventative eye health potential of carotenoids?

Are doctors seeing the preventative eye health potential of carotenoids?

James Stringham

Research doctor, University of Georgia

Natural and synthetic astaxanthin are different products, Algatech exec says

Natural and synthetic astaxanthin are different products, Algatech exec says

The natural vs synthetic astaxanthin debate centers on the fact that the products are...

Key Industry Events

 

Access all events listing

Our events, Events from partners...